Blair William & CO Amicus Therapeutics, Inc. Transaction History

Blair William & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$9.55 - $12.09 $124,264 - $157,315	13,012 Added 27.54%	60,266 $643,000
Q2 2024 Aug 12, 2024	BUY	$9.04 - $11.75 $56,382 - $73,284	6,237 Added 15.21%	47,254 $468,000
Q1 2024 May 09, 2024	BUY	$11.43 - $14.24 $1,165 - $1,452	102 Added 0.25%	41,017 $483,000
Q4 2023 Feb 12, 2024	BUY	$9.97 - $14.52 $54,446 - $79,293	5,461 Added 15.4%	40,915 $580,000
Q3 2023 Nov 09, 2023	BUY	$11.78 - $13.86 $417,648 - $491,392	35,454 New	35,454 $431,000

317

315M

530K

569K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.74B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.